2024-11-15 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**Company Overview:** UnitedHealth Group Inc. is a leading health care and insurance company offering a wide range of health benefits, insurance products, and health care services.

**Financial Performance:**

**1. Performance vs. S&P 500:**

* **Cumulative return:** UNH has generated a cumulative return of **370.25%**, outperforming the S&P 500 (VOO) with a cumulative return of **179.47%**. This represents a significant difference of **190.78%**, placing the stock in the **70.31%** percentile of its historical performance against the S&P 500. 
* **Alpha & Beta analysis:** UNH consistently displays a beta value close to 1, suggesting it tracks the market closely. However, it consistently shows a strong positive alpha, demonstrating superior performance compared to the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $605.87 (Last market: $590.22)
* **Moving Averages:** 5-day SMA: $613.41, 20-day SMA: $578.9, 60-day SMA: $583.34
* **Analysis:** The current price is above the 20 and 60-day moving averages, suggesting potential upward momentum. However, the 5-day SMA is higher, indicating a slight short-term pullback.

**3. Technical Indicators:**

* **RSI:** 70.55 - This indicates the stock is in overbought territory, potentially signaling a near-term correction.
* **PPO:** 0.99 - A high PPO value suggests strong upward momentum, supporting the RSI observation.
* **Relative Divergence:** 6.97 (+) - This indicates a short-term upward trend.
* **Expected Return:** 29.44% - This represents the potential for long-term outperformance against the S&P 500, assuming current market conditions.

**4. Recent Earnings and Forecast:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-11-04 | 6.56 | $100.82B |
| 2024-08-09 | 4.58 | $98.86B |
| 2024-05-09 | -1.53 | $99.80B |
| 2023-11-06 | 6.31 | $92.36B |
| 2024-11-04 | 6.31 | $92.36B |

* **Analysis:** The latest earnings report (2024-11-04) revealed a strong EPS of 6.56, exceeding analyst expectations. Revenue also continues to grow steadily, indicating strong business performance.

**5. Financial Data:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30 | $99.18B | 21.56% |
| 2024-06-30 | $97.86B | 21.52% |
| 2024-03-31 | $98.78B | 22.26% |
| 2023-12-31 | $93.25B | 22.33% |
| 2023-09-30 | $91.36B | 24.51% |

* **Analysis:** Revenue and profitability are consistently strong, indicating a healthy financial position.

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $94.53B | 6.41% |
| 2024-06-30 | $89.36B | 4.72% |
| 2024-03-31 | $86.69B | -1.63% |
| 2023-12-31 | $88.76B | 6.15% |
| 2023-09-30 | $84.49B | 6.91% |

* **Analysis:** Equity continues to grow, demonstrating a solid financial foundation. The ROE fluctuates, but generally remains above average, indicating efficient capital utilization.

**6. News and Recent Events:**

* **Recent Earnings News:** Please specify the specific date of the earnings release to provide a more accurate analysis.

**7. Analyst Opinions and Performance Highlights:**

* Please specify the desired date range or period for this analysis.

**8. Overall Analysis:**

UnitedHealth Group Inc. (UNH) is a strong performer within the healthcare sector, demonstrating consistent revenue growth, profitability, and outperformance against the S&P 500. While the stock is currently overbought based on technical indicators, its strong fundamentals and long-term growth potential remain attractive. Investors looking for exposure to the healthcare sector may consider UNH as a potential addition to their portfolios.

**Disclaimer:** This report is for informational purposes only and should not be considered investment advice. All investment decisions should be made with the guidance of a qualified professional after considering your personal financial situation and risk tolerance.
